Seaport Therapeutics, Inc.
SPTXNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $621.21M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $14.85$28.38
- Volume (live)
- -
- Avg. volume (3M)
- 274.30K
Seaport Therapeutics (SPTX) Stock Price & Financial Analysis
Seaport Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $17.14 - $18.00 |
|---|---|
| 52-Week High | $28.38 |
| 52-Week Low | $14.85 |
| Open | $17.63 |
| Volume (last close) | 184.54K |
| Average Volume (3M) | 274.30K |
| 50-Day MA | $22.10 |
|---|
| Market Cap | 621.21M |
|---|---|
| Shares Outstanding | 35.24M |
| Price to Book (P/B) | 1.47 |
| EV/EBITDA | -4.45 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Seaport Therapeutics at a Glance
As of the Oct 16, 2026 close, Seaport Therapeutics (SPTX) has a market capitalization of $621.21M.
As of its latest reported balance sheet, it holds $64.22M in cash and securities against $5.02M of debt, a net cash position of $59.21M.
Seaport Therapeutics does not currently pay a dividend.
At $17.83 (the Oct 16, 2026 close) it sits within its 52-week range of $14.85 to $28.38.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $38.60, 116.5% above the Oct 16, 2026 close.
Frequently Asked Questions About Seaport Therapeutics
What is the current stock price for SPTX?
As of the Oct 16, 2026 close, SPTX stock trades at $17.83. The 52-week range is $14.85–$28.38, with a day range of $17.14–$18.00.
What is the P/E ratio for SPTX?
The P/E ratio (Price-to-Earnings) for SPTX is shown in the Key Statistics section. This valuation metric helps compare Seaport Therapeutics, Inc. to industry peers.
Does SPTX pay dividends?
Seaport Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SPTX?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for SPTX is Buy. The average 12-month price target is $38.60, a 116.5% upside from the Oct 16, 2026 close of $17.83.
What is the market cap of SPTX?
As of the Oct 16, 2026 close, Seaport Therapeutics's market capitalization is $628.3M, classifying it as a small-cap company. Seaport Therapeutics operates in the Healthcare sector within the Biotechnology industry.